(Q51794535)

12 April 2018

title

Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Behçet's disease. (English)

1 reference

12 April 2018

0 references

0 references

0 references

5

1 reference

12 April 2018

author name string

Nádia Emi Aikawa

1

1 reference

12 April 2018

Carla Gonçalves

2

1 reference

12 April 2018

Clovis Artur Almeida Silva

3

1 reference

12 April 2018

Célio Gonçalves

4

1 reference

12 April 2018

Jozélio Freire de Carvalho

6

1 reference

12 April 2018

publication date

11 December 2009

1 reference

12 April 2018

Rheumatology International

published in

1 reference

12 April 2018

volume

31

1 reference

12 April 2018

issue

8

1 reference

12 April 2018

page(s)

1097-1099

1 reference

12 April 2018

https://scigraph.springernature.com/pub.10.1007/s00296-009-1276-x

exact match

0 references

cites work

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1276-X

Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1276-X

Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1276-X

Adalimumab: a new modality for Behçet's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1276-X

Cross-cultural adaptation of the Behçet's Disease Current Activity Form (BDCAF) to Brazilian Portuguese language.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1276-X

Tumor necrosis factor inhibitors: clinical implications of their different immunogenicity profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1276-X

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

21 January 2018

1 reference

12 December 2020

Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

1 reference

12 December 2020

Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature

1 reference

12 December 2020

Infliximab treatment for severe orogenital ulceration in Behçet's disease

1 reference

12 December 2020

Cytokines in Behçet's disease

1 reference

12 December 2020

Successful treatment of long-standing neuro-Behçet's disease with infliximab

1 reference

12 December 2020

[Treatment of Behçet's disease with adalimumab]

1 reference

12 December 2020

A case of mucocutaneous Behçet's disease responding to etanercept

1 reference

12 December 2020

Evaluation of the International Study Group for Behçet's Disease Criteria in Brazilian patients

1 reference

12 December 2020

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

1 reference

12 December 2020

10.1007/S00296-009-1276-X

Identifiers

DOI

1 reference

12 April 2018

PubMed ID

20012049

1 reference

12 April 2018